CD40 antisense oligonucleotide inhibition of trinitrobenzene sulphonic acid induced rat colitis

Gut

Volumn 54, Issue 1, 2005, Pages 70-77

  Gao, D ^b   Wagner, A H ^b   Fankhaenel, S ^c   Stojanovic, T ^b   Schweyer, S ^b   Panzner, S ^c   Hecker, M ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c Novosom AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CD40 ANTISENSE OLIGONUCLEOTIDE; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; INTERLEUKIN 12; MONOCYTE CHEMOTACTIC PROTEIN 1; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; COLITIS; CONTROLLED STUDY; DOWN REGULATION; DRUG DESIGN; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; ENTERITIS; GENE EXPRESSION; GENE SEQUENCE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MUCOSA INFLAMMATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIGENS, CD40; CD40 LIGAND; CELLS, CULTURED; COLITIS; CROHN DISEASE; DRUG DESIGN; GENE EXPRESSION REGULATION; IMMUNITY, MUCOSAL; INTESTINAL MUCOSA; LIPOSOMES; MALE; MUSCLE, SMOOTH, VASCULAR; OLIGONUCLEOTIDES, ANTISENSE; RATS; RATS, WISTAR; TRANSFECTION; TRINITROBENZENESULFONIC ACID; VASCULAR CELL ADHESION MOLECULE-1;

EID: 10844255792     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2003.029587     Document Type: Article

References (27)

1. van Kooten C, Bancheraeu J. CD40-CD40 ligand. J Leukoc Biol 2000;67:2-17.
2. Schoenbeck U, Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 2001;58:4-43.
3. Castigli E, Alt FW, Davidson L, et al. CD40-deficient mice generated by recombinant-activating gene-2-deficient blastocyst complementation. Proc Natl Acad Sci U S A 1994;91:12135-9.
4. Renshaw BR, Fanslow WC III, Armitage RJ, et al. Humoral immune responses in CD40-ligand-deficient mice. J Exp Med 1994;180:1889-90.
5. Razanajaona D, Van Kooten C, Lebecque S, et al. Somatic mutations in human Iq variable genes correlate with me partially functional CD40-ligand in the X-linked hyper-IgM syndrome. J Immunol 1996;15:1492-8.
6. Hollenbaugh D, Mischel-Petty N, Edwards CP, et al. Expression of functional CD40 by vascular endothelial cells. J Exp Med 1995;182:33-40.
7. Karmann K, Hughes CC, Schechner J, et al. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci U S A 1995;92:4342-6.
8. Xu J, Foy TM, Laman JD, et al. Mice deficient for the CD40 ligand. Immunity 1994;1:423-31.
9. Neurath MF, Finotto S, Glimcher LH. The role of Th1/Th2 polarization in mucosal immunity. Nat Med 2002;8:567-73.
10. Battaglia E, Biancone L, Resegotti A, et al. Expression of CD40 and its ligand, CD40L, in intestinal lesions or Crohn's disease. Am J Castroenterol 1999;94:3279-84.
11. Kawai T, Andrews D, Colvin RB, et al. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med 2000;6:114.
12. Yamada A, Sayegh MH. The CD154-CD40 costimulatory pathway in transplantation. Transplantation 2002;73(suppl 1):S36-9.
13. Andre P, Prasad KS, Denis CV, et al. CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat Med 2002;8:247-52.
14. Sakata K, Sakata A, Kong L, et al. Monocyte rescue of human T cells from apoptosis is CD40/CD154 dependent. Scand. J Immunol 1999;50:479-84.
15. Krzesz R, Wagner AH, Cattarruzza M, et al. Cytokine-inducible CD40 gene expression in vascular smooth muscle cells is mediated by nuclear factor κB and signal transducer and activator of transcription-1. FEBS Lett 1999;453:191-6.
16. Lienenlüke B, Stojanovic T, Fiebig T, et al. Thalidomide impairment of trinitrobenzene sulphonic acid-induced colitis in the rat-role of endothelial cell-leukocyte interaction. Br J Pharmacol 2001;133:1414-23.
17. Tone M, Tone Y, Fairchild PJ, et al. Regulation of CD40 function by its isoforms generated through alternative splicing. Proc Natl Acad Sci USA 2001;98:1751-6.
18. Myers KJ, Murthy S, Flanigan A, et al. Antisense oligonucleotide blockade of tumor necrosis factor-α in two murine models of colitis. J Phamacol Exp Ther 2003;304:411-24.
19. Singh B, Powire F, Mortensen NJ. Immune therapy in inflammatory bowel disease and models of colitis. Br J Surg 2001;88:1558-69.
20. Hoffmann JC, Peters K, Henschke S, et al. Role of T lymphocytes in rat 2,4,6-trinitrobenzene sulphonic acid (TNBS) induced colitis: increased mortality after γδ T cell depletion and no effect of αβ T cell depletion. Gut 2001,48:489-95.
21. Stuber E, Strober W, Neurath M. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med 1996;183:693-8.
22. Rijcken E, Krieglstein CF, Anthoni C, et al. ICAM-1 and VCAM-1 antisense oligonucleotides attenuate in vivo leukocyte adherence and inflammation in rat inflammatory bowel disease. Gut 2002;51:529-35.
23. Galbraith WM, Hobson WC, Giclas PC, et al. Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligonucleotides in the monkey. Antisense Res Dev 1994;4:201-6.
24. Cong Y, Weaver CT, Lazenby A, et al. Colitis induced by enteric bacterial antigen-specific CD4+ T cells requires CD40-CD40 ligand interactions for a sustained increase in mucosal IL-12. J Immunol 2000;165:2173-82.
25. Tozawa K, Hanai H, Sugimoto K, et al. Evidence for the critical role of interleukin-12 but not interferon-γ in the pathogenesis of experimental colitis in mice. J Gastroenterol Hepatol 2003;18:578-87.
26. + T cells by blocking the CD40-CD154 interactions. J Immunol 2000;164:6005-14.
27. De Jong YP, Comiskey M, Kalled SL, et al. Chronic murine colitis is dependent on the CD154/CD40 pathway and can be attenuated by anti-CD 154 administration. Gastroenterology 2000;119:715-23.